Full Text
Cost-Effectiveness of Treating Advanced Progressive Pancreatic Neuroendocrine Tumor Patients With Everolimus Versus Sunitinib In Sweden

Abstract

Authors

A. Perrin J. Park J. Jacob S. Welin

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×